Armenia’s Balancing Act and Double Standards
May 6, 2025
The FINANCIAL -- A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in ...
Submit guest post/Letters to the Editor:
editor (at) finchannel.com
Sales & Marketing: (+995 558) 03 03 03 Email: marketing (at) finchannel.com
Whatsup: (+995 599) 96 52 52
Georgia:
(+995 599) 96 52 52 Email: editor (@) finchannel.com
Postal address: 17 Mtskheta str. Tbilisi, Georgia 0179 The FINANCIAL